[1] 后桂荣,曾抗,周再高,等.两种鬼臼毒素脂质体的制备及其比较分析[J].第一军医大学学报,2003,23(3):216-8.Hou GR,Zeng K,Zhou ZG,et al. Preparation and comparative analysis of two podophyllotoxin liposomes[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2003,23(3):216-8. [2] 颉玉胜,曾抗,李国锋,等.脂质体影响荧光素钠透皮和皮肤贮留量的实验研究[J].第一军医大学学报,2003,23(2):110-3.Xie YS,Zeng K,Li GF,et al. Effect of liposome on permeability and drug retention of sodium fluorescein in rat skin:an experimental study[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2003,23(2):110-3. [3] 江彬彬,曾抗,张三泉,等.鬼臼毒素二棕橺酸磷脂酰胆碱脂质体局部外用的实验研究[J].第一军医大学学报,2002,22(10):875-7.Jiang BB,Zeng K,Zhang SQ,et al. Experimental study of podophyllotoxin dipalmitoylphosphatidylcholine liposome for topical skin application[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2002,22(10):875-7. [4] 张三泉,曾抗,江彬彬,等.大鼠外用脂质体鬼臼毒素后血液中鬼臼毒素浓度观察[J].第一军医大学学报,2002,22(9):782-3.Zhang SQ,Zeng K,Jiang BB,et al. Changes in serum concentration of podophyllotoxin after its topical application with liposome on rat skin[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2002,22(9):782-3. [5] 胡俊,章廉,冯筱榕,等.一种新型脂质体的制作方法[J].第一军医大学学报,2001,21(2):138-9.Hu J,Zhang L,Feng XR,et al. A method for producing a new type of liposome[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2001,21(2):138-9. [6] Rogy MA,Beinhauer BG,Reinisch W,et al. Transfer ofinterleukin-4 and interleukin-10 in patients with severe inflammatory bowel disease ofthe rectum[J]. Hum Gene Ther,2000,11 (2):1731-41. [7] Suntres ZE,shek PN. Prophylaxis against lipopoly saccharide-induced lung injuries by liposome-entrapped dexamethasone in rats[J]. Biochem Pharmacol,2000,59(90):1155-61. [8] 曾抗,李国锋,许重远,等.脂质体鬼臼毒素治疗尖锐湿疣的双盲随机对照试验[J].第一军医大学学报(J First Mil Med Univ/Di YiJun Yi Da Xue Xue Bao),1998,18(3):246. [9] Yata T,Endo Y,Sne M,et al. Amino Acids protest epithelial cells from local toxicity by absorption enhancer,sodium Laurate[J]. J Pharm Sci,2001,90(10):1456-65. [10] Yamamoto A,Tatsumi H,Maruyama M,et al. Modulation of intestinal permeability by nitric oxide donors:implications in intestinal delivery of poorly absorbable drugs[J]. J Pharmacol Exp Therap,2001,296(1):84-90. [11] 李国锋,陈建海,郭丹,等.重组人粒细胞集落刺激因子壳聚糖胶囊的制备和体外释药特性[J].中国医院药学杂志(Chin J HospPharm),2003,23(1):1-4. [12] 庞怡诺,张志荣,庞其捷,等.酶依赖结肠靶向地塞米松--葡聚糖酯及其片剂的研究[J].药学学报(Acta Pharmaceutica Sinica),2001,36(8):625-30. [13] 周四元,梅其柄,周瑾,等.糖皮质激素前体药物在大鼠胃肠道中定位转释的药代动力学[J].药学学报(Acta Pharmaceutica Sinica),2001,36(5):325-8. [14] 李国锋,陈建海,刘立捷,等.结肠菌群触发型5-氨基水杨酸壳聚糖胶囊大鼠体内的吸收与分布研究[J].第一军医大学学报,2003,23(5):431-4.Li GF,Chen JH,Liu LJ,et al. Absorption and distribution of 5-aminosalicylic acid from its chitosan capsule degraded by colon bacteria-released enzymes in rats[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2003,23(5):431-4. |